Nasdaq trade halt continues <PLTS.O> reason not available at 07:25 AM
PLTS•Trading halt notice
Nasdaq trade halt continues <PLTS.O> reason not available at 07:25 AM.
Related News
Evommune starts Phase 2b trial of EVO756 for migraine prevention
EVMN•
Vericel Q2 swings to GAAP profit of $2.2 million; revenue rises 22% to $77.5 million
VCEL•
BGC Q2 FY26 GAAP EPS rises 36.4% to USD 0.15; revenue climbs 7.8% to USD 845.5 million
BGC•
Hirtle Callaghan publishes 2Q 2026 Investment Perspective excerpt
QQQ•
Alnylam Pharmaceuticals Q2 Adjusted EPS USD 1.84 Vs. IBES Estimate USD 1.55
ALNY•